Veradigm | MDRX - Cost Of Sales


Veradigm reported $124.74M in Cost of Sales for its fiscal quarter ending in December of 2022.





Cost Of Sales Change Date
Alcidion AUD 6.82M 1.16M Dec/2025
Ambu A/S DKK 611M 24M Dec/2025
Amplifon EUR 460.17M 14.78M Sep/2025
Cardinal Health USD 63.36B 1.57B Dec/2025
Centene USD 47.59B 831M Dec/2025
Charles River Laboratories USD 722.27M 28.81M Dec/2025
Cigna USD 63.37B 1.93B Sep/2025
Coloplast 2.31B 110M Dec/2025
Computer Programs Systems USD 52.17M 9.8M Dec/2025
Convatec Group USD 515.3M 270.15M Dec/2024
CVS Health USD 92.13B 3.06B Dec/2025
Diasorin EUR 99.64M 4.71M Sep/2025
Elevance Health USD 38.07B 75M Dec/2025
General Electric Aerospace USD 8.15B 764M Mar/2026
Gulf Medical Proj AED 151.05M 11.52M Dec/2025
Humana USD 26.54B 1.15B Mar/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
Laboratory Of America USD 2.6B 56.8M Dec/2025
Maximus USD 1.05B 61.81M Dec/2025
McKesson USD 102.47B 2.86B Dec/2025
Med Life RON 283.78M 123.71M Sep/2025
Molina Healthcare USD 10.18B 91M Dec/2025
Omnicell USD 183.66M 7.53M Dec/2025
Oriola-kd EUR 461.6M 35.5M Dec/2025
Owens Minor USD 436.92M 32.62M Dec/2025
Quest Diagnostics USD 1.99B 57M Mar/2026
Rede D'or Sao Luiz BRL 6.29B 4.77B Dec/2025
Siemens Healthineers EUR 3.33B 622M Dec/2025
Sonova Holding CHF 539.4M 11.5M Dec/2025
UnitedHealth USD 94.72B 2.2B Dec/2025
Veeva Systems USD 213.48M 14.01M Dec/2025
Veradigm USD 124.74M 56.25M Dec/2022
Xerox USD 1.14B 104M Jun/2025